Prophylactic parenteral cephalosporins in surgery. Are the newer agents better?
Parenteral prophylactic cephalosporins used in surgery were compared in 17 published studies. Examination of these studies reveals little justification for preference of one cephalosporin over another. For gastrointestinal, obstetrical-gynecologic, or cardiac operations, newer cephalosporins did not result in substantial decreases in adverse postoperative clinical events (eg, wound infections, intra-abdominal and pelvic infections, and endocarditis) when compared with older cephalosporins. There is no evidence that second- or third-generation cephalosporins result in postoperative infection rates lower than with first-generation cephalosporins.
D006348:Cardiac Surgical Procedures; D002511:Cephalosporins / Q000008:administration & dosage* / Q000627:therapeutic use; D002585:Cesarean Section; D013505:Digestive System Surgical Procedures; D006801:Humans; D007045:Hysterectomy, Vaginal; D017053:Infection Control; D007263:Infusions, Parenteral; D011183:Postoperative Complications / Q000517:prevention & control; D011292:Premedication; D013530:Surgical Wound Infection / Q000517:prevention & control
D002511:Cephalosporins